Cetuximab (C225) is a monoclonal antibody targeting the human epidermal growth factor receptor (EGFR) with high affinity (Kd=0.201 nM). It inhibits tumor cell proliferation and induces apoptosis, making it a key tool for in vitro and in vivo cancer research, particularly in studying EGFR-driven oncology models.
Konzentration:
5.62 mg/mL
Molekulargewicht:
152 kDa
Reinheit:
>99.99% (May vary between batches)
CAS Nummer:
[205923-56-4]
Target-Kategorie:
EGFR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten